Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,887 | -12,065 | -9,452 | -6,702 | -3,189 |
| Depreciation Amortization | 119 | 19 | 1 | 45 | 20 |
| Accounts receivable | N/A | N/A | 0 | -2 | -31 |
| Accounts payable and accrued liabilities | -204 | -77 | 336 | 78 | 627 |
| Other Working Capital | -284 | 361 | 121 | -891 | 200 |
| Other Operating Activity | 1,073 | -1,736 | -1,815 | -551 | -1,611 |
| Operating Cash Flow | $-2,183 | $-13,498 | $-10,809 | $-8,023 | $-3,984 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -15 | -22 | -20 | -19 |
| Other Investing Activity | -4 | -24 | -17 | -19 | 0 |
| Investing Cash Flow | $-4 | $-39 | $-39 | $-39 | $-19 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,000 | 70 | 70 | 70 | N/A |
| Other Financing Activity | 0 | 10,698 | 10,698 | 5,000 | 5,000 |
| Financing Cash Flow | $10,000 | $10,768 | $10,768 | $5,070 | $5,000 |
| Beginning Cash Position | 2,761 | 5,495 | 5,495 | 5,495 | 5,495 |
| End Cash Position | 10,574 | 2,726 | 5,415 | 2,502 | 6,492 |
| Net Cash Flow | $7,813 | $-2,769 | $-80 | $-2,993 | $997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,183 | -13,498 | -10,809 | -8,023 | -3,984 |
| Capital Expenditure | N/A | -15 | -22 | -20 | -19 |
| Free Cash Flow | -2,183 | -13,513 | -10,831 | -8,043 | -4,003 |